Last update:
HIV & AIDS news
HIV & AIDS
International AIDS relief program, at 20, looks to next steps
Saturday marks a major milestone in the global fight to eliminate the AIDS epidemic, as the U.S. President's Emergency Plan for AIDS Relief celebrates its 20th anniversary as the largest commitment by a country to combat ...
Jan 27, 2023
0
5
Scientists find potential cellular target for HIV therapies
Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues ...
Jan 19, 2023
0
57
People with HIV may experience higher rates of inflammation and immune activity during pregnancy
People with HIV have a higher chance of having chronic systemic inflammation during pregnancy, according to a Rutgers study.
Jan 18, 2023
0
18
Experimental HIV vaccine regimen safe but ineffective, NIH study finds
An investigational HIV vaccine regimen tested among men who have sex with men (MSM) and transgender people was safe but did not provide protection against HIV acquisition, an independent data and safety monitoring board (DSMB) ...
Jan 18, 2023
0
4
Rapid cognitive decline uncommon in aging people with HIV on stable treatment, says study
With successful treatment, HIV has become a chronic health condition which can be managed with life-long care.
Jan 16, 2023
0
17
Researchers uncover how HIV reservoir cells resist elimination by human immune responses
Soon after infection, HIV-1 establishes a life-long presence by forming viral reservoirs in the body—cells that are infected with HIV but not actively producing new viruses. Antiretroviral therapy (ART) reduces HIV levels ...
Jan 10, 2023
0
32
Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency
Understanding HIV latency at the molecular level is crucial for efforts to eliminate the viral scourge that causes AIDS. Latent infected cell reservoirs—where the human immunodeficiency virus (HIV) hides and persists in ...
Jan 10, 2023
0
54
Cognitive behavioral intervention ups antiretroviral therapy adherence in adolescents, young adults
The Adherence Connection for Counseling, Education, and Support (ACCESS) peer-led, mobile health cognitive behavioral antiretroviral therapy (ART) adherence intervention improves adherence to ART for adolescents and young ...
Jan 9, 2023
0
2
HIV remains a leading killer in Africa despite medical breakthroughs—how to eliminate it
About 38 million people around the world are living with HIV. About 70% of them live in Africa. This shows that there is no solution to the AIDS pandemic without a solution in Africa. In 2021, there were 1.5 million new cases ...
Jan 9, 2023
0
7
Women experiencing intimate partner violence three times more likely to contract HIV
Women that experience recent intimate partner violence (IPV) are three times more likely to contract HIV, according to a new study led by McGill University researchers. In regions like Sub-Saharan Africa, women face an intersecting ...
Jan 5, 2023
0
13
Epigenetic aging associated with aberrant neural oscillatory dynamics of visuospatial processing in those with HIV
A new research paper titled "Epigenetic aging is associated with aberrant neural oscillatory dynamics serving visuospatial processing in people with HIV" has been published in Aging.
Jan 5, 2023
0
3
Collaboration to develop a mobile intervention to help Black American smokers with HIV
HIV remains a critical global public health issue and a significant threat to global health security after having claimed more than 40 million lives, according to the World Health Organization. The stark reality is that one ...
Jan 4, 2023
0
5
New HIV treatment shot given only twice a year could be a 'game changer'
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens.
Dec 30, 2022
0
57
FDA approves Sunlenca for treatment-resistant HIV
The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...
Dec 29, 2022
0
14
Cessation of Medicaid funding for neonatal circumcision examined in new study
Although it is both a religious rite and cultural practice, male circumcision is primarily done in the United States as a means of preventative health care. Yet Medicaid funding for this neonatal procedure has been decreasing ...
Dec 14, 2022
0
10
Task force recommends PrEP for reducing risk for HIV acquisition
The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation forms the basis ...
Dec 13, 2022
0
28
An ounce of prevention: Differences in HIV prevention activities among rural and urban physicians
HIV remains a major public health concern in the United States, with adolescents and young adults (15-24 years old) making up around 20 percent of new infections in the nation each year. Prevention is key to stopping HIV, ...
Dec 12, 2022
0
5
Medicaid expansion plus PrEP and antivirals could lower HIV transmission in Houston, model projects
Enacting Medicaid expansion in Texas and increasing the use of preventive and antiviral medications could result in a decline of new HIV infections among young Black gay, bisexual, and other men who have sex with men (MSM) ...
Dec 12, 2022
0
12
Recommendations updated for treatment, prevention of HIV
In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antiretroviral drugs ...
Dec 9, 2022
0
15
